Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-35399

Single-particle
3.23 Å
EMD-35399
3D View Gallery
Deposition: 17/02/2023
Map released: 05/04/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-35399
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8if3 summary report (pdf.gz) Map and 8if3 FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of human alpha-2/delta-1 with mirogabalin

EMD-35399

Single-particle
3.23 Å
EMD-35399
3D View Gallery
Deposition: 17/02/2023
Map released: 05/04/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Voltage-dependent calcium channel subunit alpha-2/delta-1
Fitted models: 8if3

Deposition Authors: Kozai D, Numoto N, Fujiyoshi Y
Recognition Mechanism of a Novel Gabapentinoid Drug, Mirogabalin, for Recombinant Human alpha 2 delta 1, a Voltage-Gated Calcium Channel Subunit.
Kozai D, Numoto N, Nishikawa K, Kamegawa A, Kawasaki S, Hiroaki Y, Irie K, Oshima A , Hanzawa H, Shimada K, Kitano Y , Fujiyoshi Y
(2023) J Mol Biol , 435 , 168049 - 168049
PUBMED: 36933823
DOI: doi:10.1016/j.jmb.2023.168049
ISSN: 1089-8638
ASTM: JMOBAK